NF-κB-IN-1

Research use only, not for human use.

NF-κB-IN-1 is a potent NF-κB signaling pathway inhibitor. It is a 4-arylidene crucumin analogue. NF-κB-IN-1 directly inhibits IKK to block NF-κB activation.

NF-κB-IN-1 is a potent NF-κB signaling pathway inhibitor. It is a 4-arylidene crucumin analogue. NF-κB-IN-1 directly inhibits IKK to block NF-κB activation. NF-κB-IN-1 effectively inhibits the viability of lung cancer cells and attenuates the clonogenic activity of A549 cells.

NF-κB-IN-1 (compound 17) (0.001-100 μM; 72 h) inhibits the growth of A549, H1944, H460 and H157 cells, with GI50s of 0.72, 0.07, 0.13, and 0.16 μM, respectively.NF-κB-IN-1 (0.5-25 μM; pretreated for 30 min or 4 h) potently blocks the IκB phosphorylation and degradation in A549 cells.NF-κB-IN-1 (0.1-100 μM; pretreated for 30 min) dose-dependently inhibits the TNFα-induced nuclear translocation of NF-κB in A549 cells, with an IC50s of 1.0 μM.NF-κB-IN-1 (0.1-0.4 μM; 9 d) inhibits lung cancer clonogenic activity. Cell Viability Assay Cell Line:A549, H1944, H460 and H157 cells Concentration:0.001, 0.01, 0.1, 1, 10, 100 μM Incubation Time:72 hours Result:Decreased viability of lung adenocarcinoma cells A549 and H1944, quamous cell carcinoma cells H157, and large cell carcinoma cells H460 in a dose-dependent manner.Western Blot Analysis Cell Line:A549 cells Concentration:0.5, 1.0, 2.5, 5.0, 10.0, 25.0 μM Incubation Time:Pretreated for 30 min or 4 hResult:Blocked IκB phosphorylation, with an IC50 of 2.8 μM.

——

1,6-Heptadiene-3,5-dione, 1,7-bis(3,4-dimethoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methylene]-, (1E,6E)-

Apoptosis

NF-κB

NF-κB

——

——

1227098-15-8

530.57

C31H30O8

>98% (HPLC)

DMSO:50 mg/mL (94.24 mM; Need ultrasonic)

O=C(/C=C/C(C=C1)=CC(OC)=C1OC)/C(C(/C=C/C(C=C2)=CC(OC)=C2OC)=O)=C/C(C=C3)=CC(OC)=C3O

——

(-20℃)

With Ice Pack

≥ 2 years